Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
McKesson
Cipla
Merck
Federal Trade Commission
Medtronic
Johnson and Johnson
Accenture

Generated: April 22, 2018

DrugPatentWatch Database Preview

LARIN 1.5/30 Drug Profile

« Back to Dashboard

Which patents cover Larin 1.5/30, and when can generic versions of Larin 1.5/30 launch?

Larin 1.5/30 is a drug marketed by Novast Labs Ltd and is included in one NDA.

The generic ingredient in LARIN 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for LARIN 1.5/30
Drug patent expirations by year for LARIN 1.5/30

US Patents and Regulatory Information for LARIN 1.5/30

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs Ltd LARIN 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 202996-001 Mar 20, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Cantor Fitzgerald
Deloitte
Farmers Insurance
Colorcon
UBS
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.